Aleve 1's, 60 CT
Published January 21, 2026 · Recall initiated: December 26, 2025
Summary
FDA records drug Class II recall D-0262-2026, published January 21, 2026 and initiated December 26, 2025. Recalling firm: GOLD STAR DISTRIBUTION INC; Status: Ongoing; Lot: All lots within expiry distributed by Gold Star Distribution. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Distributor
- US Nationwide.
- Lot
- All lots within expiry distributed by Gold Star Distribution.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAll human food products distributed from the firm. Including but not limited to: snack foods, candy, gum,January 28, 2026
- FDALUCKY ICE, Cool Mouthwash, Alcohol Free, 16.9oz, 12CT, UPC: 808829108989January 21, 2026
- FDAPersonal Care, Ice Gel, 8oz, 12 count, UPC 048155903463January 21, 2026
- FDADeodorant: a) Axe, Body Spray, Wild Spice, 6CT, 150ML, UPC: 600108736469; b) LUCKY MENS STICK DEODORANT,January 21, 2026
- FDAAdvil a) Ibuprofen, Dispenser Pack, 2 tablet packets in box containing 50 individual packets, UPC:January 21, 2026
- FDAAlka Seltzer, a) Original, 2 tablets per packet in 58 count box, UPC: 815556020033, 016500514473, b) Plus ColdJanuary 21, 2026
Questions about this recall
Was Aleve 1's, 60 CT recalled?
Yes. FDA published recall D-0262-2026 on January 21, 2026. Reported hazard: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit